Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 20, 2025 09:41 ET | Source: AlphaTON Capital

AlphaTON Bolsters Tech Leadership with New CTO to Drive AI Growth

New York, NY, Nov. 20, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital (Nasdaq: ATON), a dominant force in the Telegram and TON ecosystem - more than 1B users strong - today announced a key appointment to...
November 19, 2025 09:00 ET | Source: AlphaTON Capital

AlphaTON Capital (Nasdaq: ATON) Issues Shareholder Update on Balance Sheet Assets and Strategic Ecosystem Expansion

New York, NY, Nov. 19, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (Nasdaq: ATON) (“AlphaTON” or the “Company”), a specialized digital asset technology company focused on the Telegram ecosystem,...
November 17, 2025 15:04 ET | Source: AlphaTON Capital

AlphaTON Capital Names P2P.org as Institutional Staking Partner to Accelerate TON Treasury Yield Strategy

New York, NY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital (Nasdaq: ATON), a specialized digital asset treasury company accelerating the growth of The Open Network (TON) Telegram ecosystem,...
November 17, 2025 10:31 ET | Source: AlphaTON Capital

AlphaTON Capital Selects P2P.org as First Institutional Staking Partner for TON Treasury Operations

New York, NY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital (Nasdaq: ATON), a specialized digital asset treasury company accelerating the growth of The Open Network (TON) ecosystem, today...
November 13, 2025 08:09 ET | Source: AlphaTON Capital

AlphaTON Capital and SingularityNET Join Forces to Accelerate Telegram’s Cocoon AI – Growing the Ethical, Decentralized AI Ecosystem

Lisbon, Portugal, Nov. 13, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (Nasdaq: ATON), a leading digital asset company focused on growing the Telegram ecosystem, today announced a strategic...
November 12, 2025 07:00 ET | Source: AlphaTON Capital

AlphaTON’s Cyncado Therapeutics and Australia’s ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans

Dover, DE and Sydney, Australia, Nov. 12, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado...
November 11, 2025 08:34 ET | Source: AlphaTON Capital

AlphaTON Capital Accelerates Global Growth with Strategic Appointment of William De’Ath as Chief Partnership Officer

Lisbon, Portugal, Nov. 11, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital (Nasdaq: ATON), the digital asset treasury company building and accelerating the TON ecosystem, today announced the appointment...
November 11, 2025 08:03 ET | Source: AlphaTON Capital

AlphaTON Capital Accelerates Global Growth with Strategic Appointment of William De’Ath as Chief Partnership Officer

Lisbon, Portugal, Nov. 11, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital (Nasdaq: ATON), the digital asset treasury company building and accelerating the TON ecosystem, today announced the appointment...
November 07, 2025 07:00 ET | Source: AlphaTON Capital

Complete Tumor Regressions Observed in Preclinical Models with Co-administration of Cyncado’s A2B and A2A Receptor Antagonists and Cancer Vaccines

Dover, DE, Nov. 07, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) (“AlphaTON”) and its wholly owned oncology subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics...
November 05, 2025 06:19 ET | Source: AlphaTON Capital

AlphaTON Capital to Acquire Premier Crypto Newswire Blockchain Wire, Cementing Dominance in Digital Asset Communications via the Telegram Ecosystem

London, UK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (Nasdaq: ATON) – AlphaTON Capital, a leading investment firm focused on disruptive...